News In Brief

The long-anticipated merger between pharmaceutical giants SmithKline Beecham and Glaxo Wellcome Plc., both of Britain, more than likely will spawn a new round of takeovers in the industry, analysts said. The companies said they'll combine forces in a deal valued at $182.4 billion. The new company, to be called Glaxo SmithKline, will have about $17.5 billion in annual sales. Together the companies employ 107,000 people, although the merger will result in an unspecified number of layoffs, they said. A spokesman for SmithKline hinted the company may pursue other merger possibilities, and US drugmakers Pfizer and Warner-Lambert also are believed close to a deal.

A buying surge pushed the Nikkei index to a 2-1/2-year high on the Tokyo stock market. The 225-issue indicator closed yesterday's trading at 19,437, its best since Aug. 8, 1997, and was led by shares in Japan's leading brokerage houses and high-tech companies. The 480-point gain followed a 123-point increase last Friday.

(c) Copyright 2000. The Christian Science Publishing Society

You've read  of  free articles. Subscribe to continue.
QR Code to News In Brief
Read this article in
QR Code to Subscription page
Start your subscription today